GENERAL
Orchid Pharma Targets $80 Mn Latin American Opportunity For Exblifep
Orchid Pharma Ltd, an Indian pharmaceutical company focused on complex antibiotics, has signed a licensing and supply agreement with Latin American pharmaceutical company Laboratorio Libra to commercialise its novel antibiotic Exblifep across nine Latin American markets, targeting a potential business opportunity of approximately $80 million over 10 years. Under the agreement, Libra will receive exclusive […]
